Skip to search formSkip to main contentSkip to account menu

Hivid

Known as: HIVID Roche, Hoffman-La Roche Brand of Zalcitabine, Roche Brand of Zalcitabine 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (5)

2',3'-DideoxynucleosidesAnti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors

Narrower (6)

2',3'-dideoxycytidineneBCH-189CS-92Epivir
BW 524W91Racivir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The Preparedness of national secondary school teachers in Nairobi Province to implement HIV/AIDS Education curriculum
xv 
2002
2002
Concurrent analysis of nucleoside reverse transcriptase inhibitors in a pool of endogenous nucleosides by short‐end injection‐capillary electrochromatography on a β‐cyclodextrin‐bonded stationary…
As part of our on‐going study of the analysis of anti‐human immunodeficiency virus (HIV) nucleosides, a capillary… 
Review
2002
Review
2002
Handbook of HIV Medicine, Douglas Wilson, Sudeshni Naidoo, Linda-Gail Bekker, Mark Cotton, Gary Maartens : book review
The Oxford Handbook of HIV Medicine for Developing Countries is a long-overdue addition to the 'Oxford Handbook' series. It is… 
2002
2002
Availability of Hivid
It has been brought to my attention that many HIV treating clinicians believe that zalcitabine (Hivid) has been taken off the… 
2002
2002
Availability of Hivid : letters
It has been brought to my attention that many HIV treating clinicians believe that zalcitabine (Hivid) has been taken off the… 
2001
2001
Synthesis of nucleoside analogs and new Tat protein inhibitors
Two studies, concerning the synthesis of original nucleoside analogs regarded as an application of heterochemistry on… 
1997
1997
Effects of ddC and AZT on Locomotion and Acoustic Startle I: Acute Effects in Female Rats1
1996
1996
FDA Committee recommends clearance for HIVID combination therapy.
1993
1993
Is Antiretroviral Treatment after Percutaneous HIV Exposure Justified?
The practice of treating health care providers occupationally exposed to human immunodeficiency virus with zidovudine has become… 
1992
1992
[New, in Austria registered specialty drugs. Hivid (2',3'-dideoxycytidine; ddC)].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)